198 related articles for article (PubMed ID: 38081054)
21. Global Acoustic Speech Temporal Characteristics for Mandarin Speakers With Parkinson's Disease During Syllable Repetition and Passage Reading.
He D; Feenaughty L; Wan Q
Am J Speech Lang Pathol; 2023 Sep; 32(5):2232-2244. PubMed ID: 37625136
[TBL] [Abstract][Full Text] [Related]
22. [Acoustic analysis of prosody in females with Parkinson's disease: comparison with normal controls].
Azevedo LL; Cardoso F; Reis C
Arq Neuropsiquiatr; 2003 Dec; 61(4):999-1003. PubMed ID: 14762606
[TBL] [Abstract][Full Text] [Related]
23. The Effects of Intensive Voice Treatment in Mandarin Speakers With Parkinson's Disease: Acoustic and Perceptual Findings.
Hsu SC; Jiao Y; Berisha V; McAuliffe MJ; Lin P; Wu RM; Cheng SJ; Levy ES
Am J Speech Lang Pathol; 2022 May; 31(3):1354-1367. PubMed ID: 35394803
[TBL] [Abstract][Full Text] [Related]
24. Prominence marking in parkinsonian speech and its correlation with motor performance and cognitive abilities.
Thies T; Mücke D; Lowit A; Kalbe E; Steffen J; Barbe MT
Neuropsychologia; 2020 Feb; 137():107306. PubMed ID: 31857118
[TBL] [Abstract][Full Text] [Related]
25. A Cross-sectional Study of Perceptual and Acoustic Voice Characteristics in Healthy Aging.
Schultz BG; Rojas S; St John M; Kefalianos E; Vogel AP
J Voice; 2023 Nov; 37(6):969.e23-969.e41. PubMed ID: 34272139
[TBL] [Abstract][Full Text] [Related]
26. Vowel acoustics in Parkinson's disease and multiple sclerosis: comparison of clear, loud, and slow speaking conditions.
Tjaden K; Lam J; Wilding G
J Speech Lang Hear Res; 2013 Oct; 56(5):1485-502. PubMed ID: 23838989
[TBL] [Abstract][Full Text] [Related]
27. The effects of a simulated fMRI environment on voice intensity in individuals with Parkinson's disease hypophonia and older healthy adults.
Manes JL; Herschel E; Aveni K; Tjaden K; Parrish T; Simuni T; Corcos DM; Roberts AC
J Commun Disord; 2021; 94():106149. PubMed ID: 34543846
[TBL] [Abstract][Full Text] [Related]
28. Acoustic and perceptual speech characteristics of native Mandarin speakers with Parkinson's disease.
Hsu SC; Jiao Y; McAuliffe MJ; Berisha V; Wu RM; Levy ES
J Acoust Soc Am; 2017 Mar; 141(3):EL293. PubMed ID: 28372040
[TBL] [Abstract][Full Text] [Related]
29. The effect of speaking context on spectral- and cepstral-based acoustic features of normal voice.
Lowell SY; Hylkema JA
Clin Linguist Phon; 2016; 30(1):1-11. PubMed ID: 26595764
[TBL] [Abstract][Full Text] [Related]
30. Use of cepstral analysis for differentiating dysphonic from normal voices in children.
Esen Aydinli F; Özcebe E; İncebay Ö
Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():107-113. PubMed ID: 30554679
[TBL] [Abstract][Full Text] [Related]
31. How Well Does Diadochokinetic Task Performance Predict Articulatory Imprecision? Differentiating Individuals with Parkinson's Disease from Control Subjects.
Karlsson F; Hartelius L
Folia Phoniatr Logop; 2019; 71(5-6):251-260. PubMed ID: 31117108
[TBL] [Abstract][Full Text] [Related]
32. Voice Onset Time in Children With and Without Vocal Fold Nodules.
Colletti L; Heller Murray E
J Speech Lang Hear Res; 2023 May; 66(5):1467-1478. PubMed ID: 36940476
[TBL] [Abstract][Full Text] [Related]
33. The Relationship Between Acoustic and Kinematic Vowel Space Areas With and Without Normalization for Speakers With and Without Dysarthria.
Kuo C; Berry J
Am J Speech Lang Pathol; 2023 Aug; 32(4S):1923-1937. PubMed ID: 37105919
[TBL] [Abstract][Full Text] [Related]
34. [Acoustic analysis of prosody in females with Parkinson's disease: effect of L-dopa].
Azevedo LL; Cardoso F; Reis C
Arq Neuropsiquiatr; 2003 Dec; 61(4):995-8. PubMed ID: 14762605
[TBL] [Abstract][Full Text] [Related]
35. Acoustic investigation of stress patterns in Parkinson's disease.
Tykalova T; Rusz J; Cmejla R; Ruzickova H; Ruzicka E
J Voice; 2014 Jan; 28(1):129.e1-129.e8. PubMed ID: 24094802
[TBL] [Abstract][Full Text] [Related]
36. Acoustic Measures of Dysphonia in Amyotrophic Lateral Sclerosis.
Maffei MF; Green JR; Murton O; Yunusova Y; Rowe HP; Wehbe F; Diana K; Nicholson K; Berry JD; Connaghan KP
J Speech Lang Hear Res; 2023 Mar; 66(3):872-887. PubMed ID: 36802910
[TBL] [Abstract][Full Text] [Related]
37. Spectral/Cepstral Analyses of Phonation in Parkinson's Disease before and after Voice Treatment: A Preliminary Study.
Alharbi GG; Cannito MP; Buder EH; Awan SN
Folia Phoniatr Logop; 2019; 71(5-6):275-285. PubMed ID: 31117110
[TBL] [Abstract][Full Text] [Related]
38. Speech rate and rhythm in Parkinson's disease.
Skodda S; Schlegel U
Mov Disord; 2008 May; 23(7):985-992. PubMed ID: 18383114
[TBL] [Abstract][Full Text] [Related]
39. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
[TBL] [Abstract][Full Text] [Related]
40. Predictive value and discriminant capacity of cepstral- and spectral-based measures during continuous speech.
Lowell SY; Colton RH; Kelley RT; Mizia SA
J Voice; 2013 Jul; 27(4):393-400. PubMed ID: 23684735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
